0000000000185924

AUTHOR

H. Soto Parra

showing 2 related works from this author

P2.04-10 Early Monitoring of Blood Biomarkers to Predict Nivolumab Efficacy in NSCLC Patients

2018

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologyBlood biomarkersbusiness.industryInternal medicinemedicineNivolumabbusinessJournal of Thoracic Oncology
researchProduct

P2.04-11 An IL-8/IFN-gammma/NLR Plasma Score to Predict Nivolumab Efficacy in Patients with NSCLC

2018

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineMedicineIn patientInterleukin 8NivolumabbusinessJournal of Thoracic Oncology
researchProduct